[{"address1": "7171 Rue Frederick Banting", "city": "Saint-Laurent", "state": "QC", "zip": "H4S 1Z9", "country": "Canada", "phone": "514 332 4888", "website": "https://www.engene.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Gu\u00e9rin. The company was founded in 2023 and is based in Saint-Laurent, Canada.", "fullTimeEmployees": 31, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alex  Nichols Ph.D.", "age": 38, "title": "Chief Strategy & Operations Officer", "yearBorn": 1985, "fiscalYear": 2023, "totalPay": 504442, "exercisedValue": 0, "unexercisedValue": 3900970}, {"maxAge": 1, "name": "Mr. Ronald H. W. Cooper", "age": 60, "title": "Chief Executive Officer & Director", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony T. Cheung Ph.D.", "age": 51, "title": "Co-Founder & Chief Scientific Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 341754, "exercisedValue": 0, "unexercisedValue": 13448566}, {"maxAge": 1, "name": "Mr. John C. Brown D.Sc., FRSC, Ph.D.", "title": "Co-Founder and Member of Scientific Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Ryan Daws", "age": 49, "title": "CFO & Head of Business Development", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Joan  Connolly", "title": "Chief Technology Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Lee G. Giguere", "age": 42, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1981, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sharon  Tan", "title": "VP of Project Management & Head of Program Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raj  Pruthi F.A.C.S., M.D., M.H.A.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Erickson", "title": "Non-Executive Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.59, "open": 6.51, "dayLow": 6.0, "dayHigh": 6.7506, "regularMarketPreviousClose": 6.59, "regularMarketOpen": 6.51, "regularMarketDayLow": 6.0, "regularMarketDayHigh": 6.7506, "beta": -0.757, "forwardPE": -3.8703434, "volume": 964372, "regularMarketVolume": 964372, "averageVolume": 208496, "averageVolume10days": 338870, "averageDailyVolume10Day": 338870, "bid": 6.01, "ask": 6.23, "bidSize": 100, "askSize": 100, "marketCap": 309938336, "fiftyTwoWeekLow": 4.42, "fiftyTwoWeekHigh": 18.4, "fiftyDayAverage": 8.18, "twoHundredDayAverage": 10.260325, "currency": "USD", "enterpriseValue": 36007708, "floatShares": 16256299, "sharesOutstanding": 50976700, "sharesShort": 768333, "sharesShortPriorMonth": 797338, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.0150999995, "heldPercentInsiders": 0.13606, "heldPercentInstitutions": 0.83233, "shortRatio": 11.39, "shortPercentOfFloat": 0.02, "impliedSharesOutstanding": 58015900, "bookValue": 5.209, "priceToBook": 1.1672106, "lastFiscalYearEnd": 1698710400, "nextFiscalYearEnd": 1730332800, "mostRecentQuarter": 1722384000, "netIncomeToCommon": -123436000, "trailingEps": -2.79, "forwardEps": -1.69, "enterpriseToEbitda": -0.655, "52WeekChange": -0.13758868, "SandP52WeekChange": 0.2764505, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ENGN", "underlyingSymbol": "ENGN", "shortName": "enGene Holdings Inc.", "longName": "enGene Holdings Inc.", "firstTradeDateEpochUtc": 1643725800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "f9f4e2ed-4011-3f93-916a-f8a188a8b358", "messageBoardId": "finmb_9516520", "gmtOffSetMilliseconds": -18000000, "currentPrice": 6.08, "targetHighPrice": 40.0, "targetLowPrice": 16.0, "targetMeanPrice": 28.125, "targetMedianPrice": 30.0, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 257678000, "totalCashPerShare": 5.828, "ebitda": -54995000, "totalDebt": 24855000, "quickRatio": 19.165, "currentRatio": 19.52, "debtToEquity": 10.791, "returnOnAssets": -0.22067, "returnOnEquity": -1.23061, "freeCashflow": -23581124, "operatingCashflow": -35489000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-15"}]